SCHEMBL21019346

SCHEMBL21019346

c1ccc(-c2cc(-c3ccccc3)nc(-c3cc4oc5ccc6oc7ccccc7c6c5c4c4ccccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ MEN1 O00255 8/20 0.40
▸ HPGD P15428 7/20 0.40
▸ MAPT P10636 7/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ NTSR1 P30989 1/20 0.38
▸ ACHE P22303 1/20 0.37
▸ NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21019347 0.92 KMT2A (0.43) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019368 0.90 KMT2A (0.45) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019357 0.90 KMT2A (0.45) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019510 0.90 ALDH1A1 (0.40) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019494 0.89 KMT2A (0.39) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019730 0.88 ADORA2A (0.42) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019861 0.88 KMT2A (0.41) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL21019572 0.87 MAPK1 (0.45) KMT2AMAPK1HPGDMAPTALDH1A1
SCHEMBL21019863 0.86 KMT2A (0.40) KMT2AMAPK1MEN1HPGDMAPT
SCHEMBL22308795 0.85 MEN1 (0.45) KMT2AMAPK1MEN1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995098-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2021-05-04 — — US disclosed
US-20190152985-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152985-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 KMT2A 2031/4885MAPK1 435/4885MEN1 615/4885
US-10995098-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 KMT2A 2031/4885MAPK1 435/4885MEN1 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback